Infectious Prospective Collection for Biological Analysis
NCT06159270 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 22870
Last updated 2023-12-06
Summary
The increase in activity within medical biology laboratories linked to the arrival of new markers (in cardiology, oncology, infectious diseases, etc.) and the acceleration of technical progress have created a prominent place for automated systems and their reagent kits within these establishments.
It is in this context that CerbaXpert took the initiative to set up this research project for the collection of prospective biological samples and their analysis. It transcribes both a process of continuous improvement but also scientific development, making it possible to provide new and/or complementary data in order to improve the operation of automated systems and their reagents within medical biology laboratories. These data obtained in current practice via this study will also be compared with the technical information provided by the manufacturers of the reagents and their automatic devices.
Conditions
Interventions
- OTHER
-
Blood sample
Venuous blood sampling
Sponsors & Collaborators
-
CerbaXpert
lead OTHER
Principal Investigators
-
Barbara Pernicni, Dr · Cerba Xpert
Eligibility
- Min Age
- 18 Years
- Max Age
- 88 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-18
- Primary Completion
- 2025-05-18
- Completion
- 2025-05-18
Countries
- France
Study Locations
More Related Trials
-
Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19
NCT06142279 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Rapid Detection of COVID-19 by Portable and Connected Biosensor
NCT04367142 ·Status: COMPLETED
-
Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)
NCT05125887 ·Status: UNKNOWN
-
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159 ·Status: RECRUITING
-
Assesment of the Metabolomic Signature in COVID-19 Patients
NCT04497272 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT)
NCT04597736 ·Status: UNKNOWN ·Phase: NA
-
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
NCT06349707 ·Status: COMPLETED
-
Value of Flow Cytometry in Infectious Point of Care: Feasibility Study
NCT03912870 ·Status: COMPLETED
-
Development of an Atlas of Respiratory Host-microbiome Interactions in Healthy Volunteers
NCT06518161 ·Status: COMPLETED ·Phase: NA
-
Microbial and Cytokine Signatures in Long COVID Patients
NCT07074158 ·Status: ENROLLING_BY_INVITATION
-
Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19
NCT06703034 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]
NCT04644159 ·Status: COMPLETED
-
HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment
NCT04613297 ·Status: COMPLETED ·Phase: NA
-
Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19
NCT04930757 ·Status: UNKNOWN
-
Immunological Profiling of Patients With COVID-19 in Respiratory Distress
NCT04351711 ·Status: COMPLETED
-
Immune Changes in Severe COVID-19 Pulmonary Infections
NCT04386395 ·Status: COMPLETED
-
Prediction of Clinical Course in COVID19 Patients
NCT04377685 ·Status: COMPLETED
-
FAst and SimplE COVID-19 Causing Virus SARS-CoV-2 Detection
NCT05341635 ·Status: COMPLETED
-
Study of COVID-19 Prognostic Factors in Hospitalized Patients
NCT05102708 ·Status: COMPLETED
-
Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.
NCT06259110 ·Status: NOT_YET_RECRUITING
-
European Pathology Laboratories and COVID-19
NCT04476823 ·Status: COMPLETED
-
A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD
NCT01516437 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.
NCT05138666 ·Status: UNKNOWN ·Phase: NA
-
The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study
NCT05258643 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor
NCT04318366 ·Status: RECRUITING